It seems every year we learn another lesson from viral epidemics. Last year the so far largest and most deleterious Ebola epidemic provoked an WHO-initiated overhaul of regulatory policies, aimed at accelerating the testing of treatments and vaccines that have shown promise in animals during times of crisis. The rVSV-ZEBOV trial was one of the results of this initiative and the success of the vaccine exceptional.
For new emerging pathogens, such as the Zika virus, the focus should now be on early strategic measures. Repeatedly during the last years, scientists and medics alike have pointed out the need for unrestricted data sharing during a disease outbreak to enable instant access to all available resources and knowledge. Now it seems publishers and health care organisations are finally ready to follow suit.